{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T05:14:56Z","timestamp":1733202896764,"version":"3.30.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.prrv.2024.01.004","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:53:04Z","timestamp":1707756784000},"page":"56-65","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cAntibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care\u201d"],"prefix":"10.1016","volume":"51","author":[{"given":"Effie","family":"Skevofilax","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moustaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Loukou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Douros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.prrv.2024.01.004_b0005","doi-asserted-by":"crossref","first-page":"e13719","DOI":"10.1111\/pai.13719","article-title":"The controversy of drug hypersensitivity in patients with cystic fibrosis and review of the literature","volume":"33","author":"Tugcu","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.004_b0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/14740338.2015.994503","article-title":"Efficacy and adverse effects of drugs used to treat adult cystic fibrosis","volume":"14","author":"Chopra","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.prrv.2024.01.004_b0015","article-title":"CYSTIC FIBROSIS AND ANTIBIOTIC HYPERSENSITIVITY: PRESENT KNOWLEDGE AND PRACTICAL APPROACH","volume":"Apr-Jun;29(2 Suppl 1):29\u201337","author":"Caimmi","year":"2015","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.004_b0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jcf.2013.04.014","article-title":"Drug induced complications; can we do more?","volume":"12","author":"Peckham","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0025","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1754.1998.00197.x","article-title":"Antibiotic hypersensitivity reactions in cystic fibrosis","volume":"34","author":"Wills","year":"1998","journal-title":"J Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ACI.0b013e328355b849","article-title":"Nonimmediate \u03b2-lactam reactions in patients with cystic fibrosis","volume":"12","author":"Whitaker","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.004_b0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/17425255.2021.1836157","article-title":"The pharmacokinetics of antibiotics in cystic fibrosis","volume":"17","author":"Akkerman-Nijland","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.004_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/antibiotics11050579","article-title":"New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review","volume":"11","author":"Losito","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.004_b0045","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.rmed.2013.02.009","article-title":"Role of long term antibiotics in chronic respiratory diseases","volume":"107","author":"Suresh Babu","year":"2013","journal-title":"Respir Med"},{"issue":"11","key":"10.1016\/j.prrv.2024.01.004_b0050","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1111\/bcp.15434","article-title":"Antibiotic hypersensitivity in cystic fibrosis - Low frequency of anaphylaxis over 16 000 courses","volume":"88","author":"Kowalik","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.prrv.2024.01.004_b0055","first-page":"325","article-title":"Treatment of Staphylococcus aureus Infections","volume":"409","author":"David","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.004_b0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2013.10.002","article-title":"Hypersensitivity to antibiotics in patients with cystic fibrosis","volume":"13","author":"Roehmel","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.prrv.2024.01.004_b0065","doi-asserted-by":"crossref","unstructured":"\u015eeng\u00fcl Emeksiz Z, Metbulut P, Akyan Soyda\u015f \u015eS, Tu\u011fcu G, Cinel G, Dibek M\u0131s\u0131rl\u0131o\u011flu E. Evaluation of Frequency and Characteristics of Drug Allergy in Pediatric Patients with Cystic Fibrosis. Pediatr Allergy Immunol Pulmonol. 2022 Jun;35(2):74-78. 10.1089\/ped.2021.0165. Epub 2022 May 18. PMID: 35588286; PMCID: PMC9247676.","DOI":"10.1089\/ped.2021.0165"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.004_b0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-7022-2-10","article-title":"Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics","volume":"2","author":"Caimmi","year":"2012","journal-title":"Clin Transl Allergy"},{"journal-title":"Prevention","year":"2022","author":"Tariq","key":"10.1016\/j.prrv.2024.01.004_b0075"},{"key":"10.1016\/j.prrv.2024.01.004_b0080","doi-asserted-by":"crossref","unstructured":"Simper, Gwendolin & Celik, Alexander & Kunze-Schumacher, Heike & Blasczyk, Rainer & Bade-D\u00f6ding, Christina. (2017). Physiology and Pathology of Drug Hypersensitivity: Role of Human Leukocyte Antigens. 10.5772\/intechopen.72133.","DOI":"10.5772\/intechopen.72133"},{"key":"10.1016\/j.prrv.2024.01.004_b0085","unstructured":"Drug Adverse Event Overview. Open.fda.gov. (n.d.). Retrieved December 17,2022,https:\/\/open.fda.gov\/apis\/drug\/event\/#:\u223c:text=About%20FAERS%20data,medical%20product%20in%20a%20patient."},{"issue":"6","key":"10.1016\/j.prrv.2024.01.004_b0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcf.2010.08.010","article-title":"Antibiotic hypersensitivity in CF: drug-induced life-threatening hemolytic anemia in a pediatric patient","volume":"9","author":"Chavez","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.004_b0095","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2500\/aap.2019.40.4275","article-title":"Drug allergy","volume":"40","author":"Greenberger","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.prrv.2024.01.004_b0100","unstructured":"Pichler, W. J. (2019, December 1). Drug hypersensitivity: Classification and clinical features. UpToDate. Retrieved December 17, 2022, from https:\/\/www.uptodate.com\/contents\/drug-hypersensitivity-classification-and-clinical-features#:\u223c:text=Drug%20hypersensitivity%20reactions%20(DHR)%20 include,enhanced%20immunologic%20or%20inflammatory%20response."},{"key":"10.1016\/j.prrv.2024.01.004_b0105","unstructured":"Marwa K, Kondamudi NP. Type IV Hypersensitivity Reaction. [Updated 2022 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK562228\/."},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.anai.2016.07.039","article-title":"Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis","volume":"117","author":"Petroni","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13223-020-00494-2","article-title":"Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology","volume":"16","author":"Jeimy","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0120","doi-asserted-by":"crossref","unstructured":"Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ. The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration. J Allergy Clin Immunol Pract. 2017 Nov-Dec;5(6):1532-1542. 10.1016\/j.jaip.2017.06.017. Epub 2017 Aug 23. Erratum in: J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):323. Erratum in: J Allergy Clin Immunol Pract. 2022 Dec;10(12):3346-3347. PMID: 28843343; PMCID: PMC5681410.","DOI":"10.1016\/j.jaip.2017.06.017"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0125","doi-asserted-by":"crossref","first-page":"1124 1128","DOI":"10.1378\/chest.106.4.1124","article-title":"Allergic Reactions to Parenteral Beta-lactam Antibiotics in Patients With Cystic Fibrosis","volume":"106","author":"Pleasants","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2024.01.004_b0130","doi-asserted-by":"crossref","unstructured":"Koch C, Hjelt K, Pedersen SS, Jensen ET, Jensen T, Lanng S, Valerius NH, Pedersen M, H\u00f8iby N. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S608-11. 10.1093\/clinids\/13.supplement_7.s608. PMID: 2068467.","DOI":"10.1093\/clinids\/13.Supplement_7.S608"},{"key":"10.1016\/j.prrv.2024.01.004_b0135","first-page":"9","article-title":"Hypersensitivity reactions to intravenous antibiotics in cystic fibrosis","volume":"27","author":"Wright","year":"2018","journal-title":"Paediatr Respir Rev"},{"issue":"1","key":"10.1016\/j.prrv.2024.01.004_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/pai.12154","article-title":"Beta-lactam hypersensitivity in children with cystic fibrosis: a study in a specialized pediatric center for cystic fibrosis and drug allergy","volume":"25","author":"Matar","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.004_b0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcf.2013.12.008","article-title":"Regarding the article entitled \u201chypersensitivity to antibiotics in patients with cystic fibrosis\u201d","volume":"13","author":"Matar","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.prrv.2024.01.004_b0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/thx.2004.027953","article-title":"Antibiotic allergy in cystic fibrosis","volume":"60","author":"Parmar","year":"2005","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcf.2006.11.001","article-title":"Beta-lactam allergy in adults with cystic fibrosis","volume":"6","author":"Burrows","year":"2007","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/pai.13206","article-title":"The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients","volume":"31","author":"Braun","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0165","doi-asserted-by":"crossref","unstructured":"Anstey KM, Lee M, Dawson D, Jue V, Budzik JM, Yu M, Kleinhenz ME, Otani IM. Antibiotic adverse reactions in adult cystic fibrosis patients. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3631-3633.e1. 10.1016\/j.jaip.2020.06.060. Epub 2020 Jul 14. PMID: 32673878.","DOI":"10.1016\/j.jaip.2020.06.060"},{"key":"10.1016\/j.prrv.2024.01.004_b0170","doi-asserted-by":"crossref","unstructured":"Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. Lancet. 2019 Jan 12;393(10167):183-198. 10.1016\/S0140-6736(18)32218-9. Epub 2018 Dec 14. PMID: 30558872; PMCID: PMC6563335.","DOI":"10.1016\/S0140-6736(18)32218-9"},{"issue":"8","key":"10.1016\/j.prrv.2024.01.004_b0175","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fimmu.2017.00614","article-title":"Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis","volume":"29","author":"Monta\u00f1ez","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0185","doi-asserted-by":"crossref","unstructured":"Liu, Hans H. MD\u2217,\u2020; Mutneja, Hemant MD\u2021; Buckley, Meghan MS\u00a7; Cushinotto, Lisa PharmD\u2225. Trends in Antimicrobial Allergies in Patients Seen in Infectious Disease Consultation During Selected Periods 2007\u20132016: Increases in Multidrug-Intolerant Individuals but Relative Stability in Antimicrobial Allergy Prevalence. Infectious Diseases in Clinical Practice 30(2):p 1-7, March 2022. | 10.1097\/IPC.0000000000001129.","DOI":"10.1097\/IPC.0000000000001129"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.004_b0190","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jaip.2020.12.051","article-title":"Piperacillin- Tazobactam Hypersensitivity: A Large, Multicenter Analysis","volume":"9","author":"Casimir-Brown","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.prrv.2024.01.004_b0195","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/ppul.26073","article-title":"Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study","volume":"57","author":"S\u00fcleyman","year":"2022","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.prrv.2024.01.004_b0200","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0897190014546109","article-title":"Beta-lactam hypersensitivity and cross-reactivity","volume":"27","author":"Terico","year":"2014","journal-title":"J Pharm Pract"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.004_b0205","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2010.06.052","article-title":"IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems","volume":"126","author":"Romano","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.prrv.2024.01.004_b0210","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jemermed.2011.05.035","article-title":"The use of cephalosporins in penicillin-allergic patients: a literature review","volume":"42","author":"Campagna","year":"2012","journal-title":"J Emerg Med"},{"key":"10.1016\/j.prrv.2024.01.004_b0215","doi-asserted-by":"crossref","unstructured":"Legere HJ 3rd, Palis RI, Rodriguez Bouza T, Uluer AZ, Castells MC. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J Cyst Fibros. 2009 Dec;8(6):418-24. 10.1016\/j.jcf.2009.08.002. Epub 2009 Sep 8. PMID: 19740711; PMCID: PMC2787787.","DOI":"10.1016\/j.jcf.2009.08.002"},{"issue":"4","key":"10.1016\/j.prrv.2024.01.004_b0220","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2011.02.002","article-title":"Rapid desensitization for non-immediate reactions in patients with cystic fibrosis","volume":"10","author":"Whitaker","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.prrv.2024.01.004_b0225","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.anai.2014.05.014","article-title":"Continuous intravenous \u03b2-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity","volume":"113","author":"Breuer","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0230","doi-asserted-by":"crossref","unstructured":"Pittman JE, Khan U, Laguna TA, Heltshe S, Goss CH, Sanders DB. Rates of adverse and serious adverse events in children with cystic fibrosis. J Cyst Fibros. 2021 Nov;20(6):972-977. 10.1016\/j.jcf.2021.02.013. Epub 2021 Mar 18. PMID: 33745860; PMCID: PMC8448791.","DOI":"10.1016\/j.jcf.2021.02.013"},{"key":"10.1016\/j.prrv.2024.01.004_b0235","doi-asserted-by":"crossref","unstructured":"Pannu AK, Saroch A. Diagnostic criteria for drug rash and eosinophilia with systemic symptoms. J Family Med Prim Care. 2017 Jul-Sep;6(3):693-694. 10.4103\/2249-4863.222050. PMID: 29417040; PMCID: PMC5787987.","DOI":"10.4103\/2249-4863.222050"},{"issue":"3","key":"10.1016\/j.prrv.2024.01.004_b0240","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12016-015-8503-x","article-title":"The Epidemiology of Anaphylaxis","volume":"54","author":"Yu","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.prrv.2024.01.004_b0245","doi-asserted-by":"crossref","unstructured":"Roehmel JF, Staab D. Answer to \u201cletter to the editor\u201d concerning the article \u201chypersensitivity to antibiotics in patients with cystic fibrosis\u201d by Roehmel et al. J Cyst Fibros. 2014 May;13(3):355-6. 10.1016\/j.jcf.2014.02.003. Epub 2014 Mar 11. PMID: 24636810.","DOI":"10.1016\/j.jcf.2014.02.003"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:43:05Z","timestamp":1733161385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054224000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"alternative-id":["S1526054224000149"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.004","relation":{},"ISSN":["1526-0542"],"issn-type":[{"type":"print","value":"1526-0542"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cAntibiotic hypersensitivity reactions in Cystic Fibrosis: A thorough inspection on a stumbling block in patient care\u201d","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2024.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}